X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3456) 3456
Publication (302) 302
Newsletter (55) 55
Book Review (37) 37
Magazine Article (17) 17
Book Chapter (14) 14
Dissertation (12) 12
Newspaper Article (10) 10
Conference Proceeding (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2505) 2505
indinavir (1905) 1905
hiv infections - drug therapy (1501) 1501
male (1323) 1323
adult (1137) 1137
female (1024) 1024
infectious diseases (964) 964
hiv protease inhibitors - therapeutic use (811) 811
indinavir - therapeutic use (751) 751
anti-hiv agents - therapeutic use (739) 739
drug therapy, combination (734) 734
immunology (703) 703
hiv (670) 670
pharmacology & pharmacy (663) 663
protease inhibitors (645) 645
middle aged (641) 641
virology (602) 602
ritonavir (554) 554
viral load (528) 528
antiretroviral therapy (501) 501
hiv infections - virology (460) 460
indinavir - adverse effects (460) 460
hiv protease inhibitors - adverse effects (458) 458
cd4 lymphocyte count (454) 454
zidovudine (418) 418
aids (411) 411
hiv protease inhibitors - pharmacology (377) 377
index medicus (366) 366
hiv-1 - drug effects (347) 347
human-immunodeficiency-virus (346) 346
saquinavir (346) 346
reverse transcriptase inhibitors - therapeutic use (344) 344
indinavir - pharmacology (330) 330
hiv protease inhibitors - administration & dosage (329) 329
indinavir - administration & dosage (327) 327
therapy (324) 324
hiv-1 (323) 323
infection (315) 315
pharmacokinetics (315) 315
nelfinavir (305) 305
hiv protease inhibitors - pharmacokinetics (304) 304
antiviral agents (301) 301
hiv infection (298) 298
animals (291) 291
rna, viral - blood (290) 290
lamivudine (289) 289
antiretroviral therapy, highly active (286) 286
anti-hiv agents - adverse effects (280) 280
anti-hiv agents - administration & dosage (279) 279
ritonavir - therapeutic use (273) 273
drug therapy (272) 272
microbiology (271) 271
hiv infections - immunology (267) 267
lamivudine - therapeutic use (265) 265
zidovudine - therapeutic use (262) 262
indinavir - pharmacokinetics (257) 257
hiv-1 - genetics (256) 256
treatment outcome (256) 256
highly active antiretroviral therapy (231) 231
immunodeficiency-virus infection (212) 212
medicine, general & internal (211) 211
drug interactions (210) 210
hiv protease inhibitors - blood (207) 207
protease inhibitor (198) 198
acquired immunodeficiency syndrome - drug therapy (196) 196
hiv infections - blood (192) 192
hiv infections - complications (188) 188
active antiretroviral therapy (187) 187
lopinavir (186) 186
adolescent (184) 184
prospective studies (176) 176
resistance (172) 172
aged (170) 170
saquinavir - therapeutic use (168) 168
time factors (168) 168
research (165) 165
human immunodeficiency virus (160) 160
indinavir - blood (158) 158
anti-hiv agents - pharmacology (155) 155
cohort studies (154) 154
drug administration schedule (154) 154
ritonavir - administration & dosage (153) 153
health aspects (149) 149
adults (144) 144
amprenavir (144) 144
chemistry, analytical (144) 144
plasma (144) 144
anti-hiv agents - pharmacokinetics (143) 143
antiretrovirals (142) 142
ritonavir - pharmacology (142) 142
efavirenz (141) 141
risk factors (141) 141
combination therapy (140) 140
stavudine - therapeutic use (140) 140
retrospective studies (139) 139
viruses (138) 138
hiv-1 - isolation & purification (137) 137
indinavir, adverse reactions (137) 137
nelfinavir - therapeutic use (137) 137
dose-response relationship, drug (135) 135
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3332) 3332
French (79) 79
Spanish (71) 71
German (33) 33
Portuguese (14) 14
Japanese (12) 12
Italian (6) 6
Dutch (5) 5
Chinese (4) 4
Russian (3) 3
Danish (2) 2
Lithuanian (1) 1
Polish (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


AIDS, ISSN 0269-9370, 01/2012, Volume 26, Issue 3, pp. 303 - 314
Journal Article
Biomaterials, ISSN 0142-9612, 2014, Volume 37, pp. 383 - 394
Journal Article
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 03/2011, Volume 150, Issue 2, pp. 204 - 211
Long-term antiretroviral therapy (ART) for human immunodeficiency virus type one (HIV-1) infection shows limitations in pharmacokinetics and biodistribution... 
Nanoparticles | HIV | Monocyte | Crystalline | Antiretroviral | Nanomedicine | Macrophage | CELLS | HUMAN-IMMUNODEFICIENCY-VIRUS | CHEMISTRY, MULTIDISCIPLINARY | ANTI-HIV DRUGS | ADHERENCE | DELIVERY | PHYSICOCHEMICAL PROPERTIES | THERAPY | PHARMACOKINETICS | WATER-SOLUBLE DRUGS | PHARMACOLOGY & PHARMACY | Indinavir - administration & dosage | Nanoparticles - chemistry | Humans | Benzoxazines - metabolism | Indinavir - pharmacology | Microbial Sensitivity Tests | Macrophages - virology | Atazanavir Sulfate | Ritonavir - pharmacology | Indinavir - metabolism | Microscopy, Electron, Transmission | Virus Replication - drug effects | Microscopy, Electron, Scanning | Pyridines - administration & dosage | Benzoxazines - administration & dosage | Ritonavir - administration & dosage | HIV-1 - drug effects | Anti-Retroviral Agents - pharmacology | Oligopeptides - metabolism | Static Electricity | Anti-Retroviral Agents - metabolism | Particle Size | Macrophages - metabolism | Pyridines - metabolism | Ritonavir - metabolism | Anti-Retroviral Agents - administration & dosage | Benzoxazines - pharmacology | Macrophages - drug effects | Oligopeptides - administration & dosage | Pyridines - pharmacology | Surface-Active Agents - chemistry | Oligopeptides - pharmacology | Highly active antiretroviral therapy | Antiviral agents | Macrophages | Analysis | Particle size | Surface charge | Ritonavir | antiretroviral therapy | Cytotoxicity | Drug delivery | Coatings | Surfactants | Efavirenz | Infection | Monocytes | nanoparticles | Physical characteristics | Antiviral activity | Replication | Pharmacokinetics | Controlled release | Indinavir | antiretroviral | crystalline | macrophage | monocyte | nanomedicine
Journal Article
Journal Article
Retrovirology, ISSN 1742-4690, 09/2010, Volume 7, Issue 1, pp. 78 - 78
Background: HIV reservoirs are rapidly established after infection, and the effect of HAART initiated very early during acute infection on HIV reservoirs... 
VIRAL LOAD | VIROLOGY | LYMPHOID-TISSUE | POSTEXPOSURE PROPHYLAXIS | ACTIVE ANTIRETROVIRAL THERAPY | CD4(+) T-CELLS | PERIPHERAL-BLOOD | HIV-1 INFECTION | BLOOD MONONUCLEAR-CELLS | MASS-SPECTROMETRY | P-GLYCOPROTEIN | Simian Acquired Immunodeficiency Syndrome - metabolism | Zidovudine - metabolism | Lamivudine - administration & dosage | Indinavir - administration & dosage | HIV Protease Inhibitors - metabolism | Macaca fascicularis | Male | Administration, Cutaneous | Reverse Transcriptase Inhibitors - administration & dosage | Zidovudine - administration & dosage | Tissue Distribution | Simian Acquired Immunodeficiency Syndrome - virology | Time Factors | Lamivudine - therapeutic use | Reverse Transcriptase Inhibitors - therapeutic use | Viremia - metabolism | Indinavir - metabolism | Drug Administration Schedule | Administration, Oral | Lamivudine - metabolism | HIV Protease Inhibitors - administration & dosage | Viremia - drug therapy | HIV Protease Inhibitors - therapeutic use | Antiretroviral Therapy, Highly Active | Animals | Simian Acquired Immunodeficiency Syndrome - drug therapy | Viremia - virology | Zidovudine - therapeutic use | Reverse Transcriptase Inhibitors - metabolism | Simian Immunodeficiency Virus | Indinavir - therapeutic use | Highly active antiretroviral therapy | Causes of | Research | Diagnosis | Simian immunodeficiency virus | Drug therapy | Health aspects | HIV infection | Viremia | Lamivudine | HIV Protease Inhibitors | Life Sciences | Human health and pathology | Simian Acquired Immunodeficiency Syndrome | Infectious diseases | Reverse Transcriptase Inhibitors | Zidovudine | Indinavir
Journal Article
AIDS Research and Human Retroviruses, ISSN 0889-2229, 01/2015, Volume 31, Issue 1, pp. 17 - 114
Journal Article
Rapid Communications in Mass Spectrometry, ISSN 0951-4198, 05/2007, Volume 21, Issue 9, pp. 1485 - 1496
Journal Article
AIDS, ISSN 0269-9370, 05/2001, Volume 15, Issue 7, pp. F11 - F18
Journal Article
AIDS, ISSN 0269-9370, 03/2002, Volume 16, Issue 4, pp. 551 - 560
Objectives: To demonstrate the feasibility of a concentration-control led approach to combination antiretroviral therapy, and to compare the virological... 
Therapeutic drug monitoring | Drug concentrations | Combination therapy | Pharmacokinetics | Antiretroviral therapy | INDINAVIR | INFECTIOUS DISEASES | DRUG-THERAPY | PROTEASE INHIBITOR THERAPY | antiretroviral therapy | ADULTS | IMMUNOLOGY | drug concentrations | CLINICAL PHARMACOKINETICS | LAMIVUDINE | VIROLOGY | ZIDOVUDINE | VIROLOGICAL FAILURE | ACUTE LYMPHOBLASTIC-LEUKEMIA | pharmacokinetics | IMMUNODEFICIENCY-VIRUS TYPE-1 | combination therapy | therapeutic drug monitoring | Lamivudine - administration & dosage | Indinavir - administration & dosage | Prospective Studies | Reverse Transcriptase Inhibitors - blood | Humans | Middle Aged | Zidovudine - pharmacokinetics | Male | RNA, Viral - blood | Reverse Transcriptase Inhibitors - administration & dosage | Feasibility Studies | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Dose-Response Relationship, Drug | HIV Infections - immunology | Indinavir - blood | Reverse Transcriptase Inhibitors - pharmacokinetics | HIV Protease Inhibitors - pharmacokinetics | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Anti-HIV Agents - blood | Reverse Transcriptase Inhibitors - therapeutic use | HIV Protease Inhibitors - blood | Indinavir - pharmacokinetics | HIV-1 - drug effects | HIV Infections - virology | Lamivudine - blood | CD4 Lymphocyte Count | HIV Protease Inhibitors - administration & dosage | Lamivudine - pharmacokinetics | HIV-1 - genetics | HIV Protease Inhibitors - therapeutic use | Anti-HIV Agents - pharmacokinetics | HIV Infections - drug therapy | Zidovudine - therapeutic use | Zidovudine - blood | Indinavir - therapeutic use
Journal Article